Lee John Sang
Insider CIK 1755665 · PHAS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 24,750 | — | $0 | 24,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 115,500 | — | $0 | 115,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-02-05 | 2021-02-09 | 76,500 | — | $0 | 76,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |